Results 61 to 70 of about 16,260 (155)

Identification of a novel ltaS mutation in daptomycin heteroresistant community-acquired methicillin-resistant Staphylococcus aureus ST72 strains in South Korea

International Journal of Infectious Diseases
Daptomycin has been used globally since 2003, with a corresponding increase in daptomycin nonsusceptible (DNS) Staphylococcus aureus. In South Korea, daptomycin became available in 2020, but emerging resistance has posed early therapeutic challenges.
Sun Hee Park, Chulmin Park, Hye-Sun Chun, Dong-Gun Lee   +3 more
doaj   +1 more source

Dose-dependent effect of daptomycin on the artificial prolongation of prothrombin time in coagulation abnormalities: in vitro verification

BMC Pharmacology and Toxicology, 2017
Background Several studies have reported that daptomycin induced artificial prolongation of prothrombin time (PT) in some test reagents, particularly in warfarin users.
Hideki Hashimoto, Makoto Saito, Naoki Kanda, Takehito Yamamoto, Makiko Mieno, Shuji Hatakeyama   +5 more
doaj   +1 more source

Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?

Infectious Diseases and Therapy, 2019
Introduction Previous series on the use of daptomycin in enterococcal infective endocarditis (EIE) have shown various outcomes, including higher mortality rates. We analyzed the effectiveness of high-dose daptomycin for the treatment of EIE.
Maddalena Peghin, Alessandro Russo, Filippo Givone, Martina Ingani, Elena Graziano, Matteo Bassetti   +5 more
doaj   +1 more source

Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.

PLoS ONE
BackgroundIn the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs), vancomycin stands as the prevalent therapeutic agent.
Yau Adamu, Mireia Puig-Asensio, Bashir Dabo, Marin L Schweizer   +3 more
doaj   +1 more source

Bone penetration of daptomycin in diabetic patients with bacterial foot infections

International Journal of Infectious Diseases, 2019
Objectives: Daptomycin has shown clinical efficacy in diabetic foot infections (DFI). However, only limited data are available on its bone penetration in this particular population. The aim of this study was to determine daptomycin bone concentrations in
Antoine Grillon, Xavier Argemi, Jeannot Gaudias, Cécile Ronde-Ousteau, Cyril Boeri, Jean-Yves Jenny, Yves Hansmann, Nicolas Lefebvre, François Jehl   +8 more
doaj   +1 more source

Dose-dependent artificial prolongation of prothrombin time by interaction between daptomycin and test reagents in patients receiving warfarin: a prospective in vivo clinical study

Annals of Clinical Microbiology and Antimicrobials, 2017
Background Daptomycin has been reported to cause artificial prolongation of prothrombin time (PT) by interacting with some test reagents of PT. This prolongation was particularly prominent with high concentrations of daptomycin in vitro. However, whether
Makoto Saito, Shuji Hatakeyama, Hideki Hashimoto, Takumitsu Suzuki, Daisuke Jubishi, Makoto Kaneko, Yukio Kume, Takehito Yamamoto, Hiroshi Suzuki, Hiroshi Yotsuyanagi   +9 more
doaj   +1 more source

De Novo Daptomycin-Nonsusceptible Enterococcal Infections

Emerging Infectious Diseases, 2012
Potential emergence of enterococcal daptomycin nonsusceptibility among patients with no prior exposure to daptomycin poses clinical and public health challenges.
Theodoros Kelesidis, Romney Humphries, Daniel Z. Uslan, David Pegues   +3 more
doaj   +1 more source

Comparative Activity of Daptomycin and Teicoplanin against Enterococci Isolated from Blood and Urine

Canadian Journal of Infectious Diseases, 1992
The authors compared the activity of daptomycin with that of ampicillin, penicillin, teicoplanin and vancomycin against 304 strains of Enterococcus species isolated from blood and urine.
Kevin R Forward, Patricia DeGagne, Kathryn R Bartlett, Godfrey K Harding   +3 more
doaj   +1 more source

Does daptomycin still have a part to play in the treatment of Enterococcus faecium bacteremia in the intensive care unit? [PDF]

Crit Care
Herbel S, Dumas G, Urbina T.
europepmc   +1 more source

Treatment outcomes of daptomycin- and vancomycin-resistant <i>Enterococcus faecium</i> bloodstream infection. [PDF]

JAC Antimicrob Resist
Lin WT, Yang JL, Lin CY, Huang SH, Chuang YC, Wang JT, Chen YC, Chang SC.   +7 more
europepmc   +1 more source